FOLLMANN MARKUS has a total of 14 patent applications. Its first patent ever was published in 2010. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ANGION BIOMEDICA CORP, AXIKIN PHARMACEUTICALS INC and ACETYLON PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 14 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Follmann Markus | 14 |
#2 | Stasch Johannes-Peter | 11 |
#3 | Griebenow Nils | 11 |
#4 | Wunder Frank | 11 |
#5 | Redlich Gorden | 11 |
#6 | Li Volkhart Min-Jian | 9 |
#7 | Ackerstaff Jens | 8 |
#8 | Knorr Andreas | 6 |
#9 | Lang Dieter | 4 |
#10 | Bärfacker Lars | 2 |
Publication | Filing date | Title |
---|---|---|
US2014171434A1 | Substituted imidazopyridines and imidazopyridazines and the use thereof |